What happened in optometry this week: July 22 - July 26
Catch up on what happened in optometry during the week of July 22-July 26.
Catch up with what Optometry Times shared this week:
Bausch + Lomb acquires Trukera Medical, ophthalmic medical diagnostic company
By David Hutton, Managing Editor, Ophthalmology Times
Bausch + Lomb Corp. announced an affiliate has acquired Trukera Medical, from its private equity owner, AccelMed Partners, and other shareholders.
According to the company, the tuck-in acquisition will help expand Bausch + Lomb’s surgical presence in the United States and contribute to its leading position in dry eye.
OGS Executive Director Lois Schoenbrun announces retirement
By Grace Koennecke
Optometry Giving Sight (OGS) recently announced Lois Schoenbrun, FAAO, the executive director of OGS, will retire from the organization in December 2024. The announcement comes after Schoenbrun came out of retirement in 2022 to serve as interim executive director for OGS, according to a news release.
Supplements slow disease progression during late stage of dry AMD, study suggests
By David Hutton, Managing Editor, Ophthalmology Times
A team of researchers at the National Institutes of Health (NIH), in a new analysis of data, have found that taking a daily supplement containing antioxidant vitamins and minerals can slow the progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision.
According to an NIH/National Eye Institute news release, the researchers examined the original retinal scans of participants in the Age-Related Eye Diseases Studies (AREDS and AREDS2) and found that, for people with late-stage dry AMD, taking the antioxidant supplement slowed expansion of geographic atrophy (GA) regions towards the central foveal region of the retina.
Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd. sign new collaboration agreement
By Grace Koennecke
Eyenovia, Inc., a commercial-stage ophthalmic company, has entered into a collaboration agreement with Senju Pharmaceutical Co., Ltd. With the two companies joining forces, they intend to work to develop Senju’s corneal epithelial wound healing candidate, SJP-0035, for use alongside Eyenovia’s Optejet® dispensing technology, aiming to use both products as a potential treatment for chronic dry eye disease.
Stability is an important quality in toric lenses
By Erin Rueff, OD, PHD, FAAO
Historically, constraints such as limited parameter availability, lens rotation, and unreliable stabilization methods meant that some optometrists avoided prescribing soft toric contact lenses. The perception was that soft toric contact lenses took more chair time than they were worth and did not deliver visual outcomes that outperformed spherical options, especially for patients with low amounts of astigmatism. For some, a few bad experiences with toric lenses 10 or even 20 years ago may have left a negative impression that persists.
